难以确定从β-素变体释放的β-素-7的不良影响-一篇评论
Marta Liliane de Vasconcelos1, Luisa Maria F S Oliveira1, Jeremy Paul Hill2
1Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of São Paulo, Pirassununga 13635-900, SP, Brazil.
Foods (Basel, Switzerland)
|September 9, 2023
概括
β-Casomorphin-7 (BCM-7),来自β-casein (β-CN) 的,可能会影响肠道健康和微生物群-肠道-大脑轴. 需要进一步的体内研究来证实BCM-7的存在.
科学领域:
- 胃肠病学 胃肠病学
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- β-Casomorphin-7 (BCM-7) 是一种由β-casein (β-CN) 衍生的生物活性.
- BCM-7与肠道,免疫系统和潜在的中枢神经系统中的μ-阿片类受体相互作用.
- 新兴研究将BCM-7与胃肠道炎症和腹部不适等症状联系起来.
研究的目的:
- 审查目前关于BCM-7对健康影响的证据.
- 探索BCM-7与微生物群-肠-大脑轴之间的潜在相关性.
- 讨论BCM-7研究中的挑战,包括人口易感性和暴露值.
主要方法:
- 关于BCM-7及其影响的现有研究的文献综述.
- 分析BCM-7行动的拟议机制.
- 讨论围绕BCM-7研究的局限性和争议.
主要成果:
- 有证据表明,BCM-7可能调节胃肠道的炎症反应.
- 假设BCM-7与微生物群-肠-大脑轴之间存在联系.
- 研究表明,潜在的不良影响可能是人群特异性的,但令人信服的体内数据有限.
结论:
- 有可信的迹象表明,β-CN A1/BCM-7与不良健康影响之间存在关联.
- 进一步的体内研究至关重要,以确认BCM-7的生理作用.
- 确定BCM-7暴露值和了解基因型特定释放是关键的研究挑战.
相关概念视频
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...


